Largest health care pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 health care pharmaceutical companies ranked by total assets, at CHF 175.5B, ahead of Johnson & Johnson (CHF 168B) and Sanofi (CHF 118.6B). Figures as of 19 Nov 2026, 15:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerCHF 175.5B
- Median
- CHF 3B
- Combined market value
- CHF 4.19T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | CHF 175.5B | CHF 132.9B | CHF 23.31 | 1.50% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | CHF 168B | CHF 540.5B | CHF 224.53 | 2.36% down | 34% up | ||
| 3 | SanofiSNY · Health Care | CHF 118.6B | CHF 93.4B | CHF 38.90 | 2.10% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | CHF 115.4B | CHF 278.9B | CHF 113.13 | 2.63% down | 45% up | ||
| 5 | AbbVieABBV · Health Care | CHF 113B | CHF 420.7B | CHF 237.99 | 1.33% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | CHF 96.2B | CHF 229.9B | CHF 148.25 | 1.66% down | 1% up | ||
| 7 | Eli LillyLLY · Health Care | CHF 94.8B | CHF 1.02T | CHF 1,139.72 | 2.26% down | 33% up | ||
| 8 | NovartisNVS · Health Care | CHF 93.6B | CHF 241.5B | CHF 127.85 | 2.32% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | CHF 81.9B | CHF 57.7B | CHF 18.07 | 0.75% up | 51% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | CHF 75.9B | CHF 100.2B | CHF 49.04 | 2.37% down | 30% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | CHF 73.1B | CHF 152.9B | CHF 88.28 | 0.20% up | 16% down | ||
| 12 | GSKGSK · Health Care | CHF 68.4B | CHF 81.1B | CHF 40.48 | 1.18% down | 5% up | ||
| 13 | Novo NordiskNVO · Health Care | CHF 67.9B | CHF 145.4B | CHF 32.98 | 0.80% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | CHF 34.4B | CHF 39.3B | CHF 33.64 | 5.54% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | CHF 34.2B | CHF 80.9B | CHF 782.10 | 1.91% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | CHF 31.4B | CHF 19.4B | CHF 16.88 | 1.31% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | CHF 21.6B | CHF 112.8B | CHF 444.74 | 1.69% down | 27% up | ||
| 18 | GrifolsGRFS · Health Care | CHF 18.4B | CHF 4.8B | CHF 7.02 | 1.71% down | 0% up | ||
| 19 | Royalty PharmaRPRX · Health Care | CHF 16.5B | CHF 33.1B | CHF 57.52 | 0.67% down | 79% up | ||
| 20 | ZoetisZTS · Health Care | CHF 13B | CHF 28.4B | CHF 69.84 | 3.21% down | 26% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | CHF 11.3B | CHF 11.3B | CHF 22.59 | 0.32% up | 26% up | ||
| 22 | GenmabGMAB · Health Care | CHF 10.9B | CHF 26.8B | CHF 43.52 | 1.26% up | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | CHF 9.8B | CHF 13.1B | CHF 203.50 | 2.60% down | 41% up | ||
| 24 | BeOne MedicinesONC · Health Care | CHF 6.9B | CHF 38.6B | CHF 337.96 | 0.70% down | 16% up | ||
| 25 | United TherapeuticsUTHR · Health Care | CHF 6.6B | CHF 20.1B | CHF 470.80 | 3.30% down | 22% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | CHF 6.4B | CHF 10.3B | CHF 53.40 | 3.08% up | 17% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 5.2B | CHF 10.5B | CHF 12.55 | 0.68% down | 8% up | ||
| 28 | Roivant SciencesROIV · Health Care | CHF 4.8B | CHF 24B | CHF 33.12 | 1.40% up | 91% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | CHF 4.2B | CHF 16.6B | CHF 124.28 | 1.36% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | CHF 3.1B | CHF 6.3B | CHF 18.15 | 1.65% down | 90% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | CHF 3B | CHF 3.8B | CHF 22.81 | 1.22% down | 63% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | CHF 2.4B | CHF 4.2B | CHF 50.77 | 0.05% down | 21% down | ||
| 33 | AlkermesALKS · Health Care | CHF 2.1B | CHF 6.6B | CHF 39.12 | 0.99% down | 66% up | ||
| 34 | InsmedINSM · Health Care | CHF 1.9B | CHF 25.5B | CHF 116.07 | 14.90% up | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | CHF 1.5B | CHF 2.6B | CHF 13.37 | 2.40% down | 41% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | CHF 1.3B | CHF 4.9B | CHF 247.01 | 1.94% down | 50% up | ||
| 37 | Ascendis PharmaASND · Health Care | CHF 1.2B | CHF 14.8B | CHF 225.09 | 1.26% down | 29% up | ||
| 38 | CytokineticsCYTK · Health Care | CHF 1.2B | CHF 6B | CHF 42.89 | 0.90% down | 19% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 1.2B | CHF 5.2B | CHF 36.99 | 1.75% up | 13% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 1.1B | CHF 7.8B | CHF 334.85 | 0.25% down | 27% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | CHF 896.6M | CHF 8.4B | CHF 55.77 | 0.02% up | 117% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | CHF 790.9M | CHF 7.5B | CHF 268.03 | 4.14% up | 86% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | CHF 790.7M | CHF 4.1B | CHF 23.60 | 0.63% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | CHF 789.3M | CHF 12.9B | CHF 66.47 | 1.04% up | 21% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | CHF 710.7M | CHF 5.2B | CHF 79.08 | 1.39% up | 34% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | CHF 705.5M | CHF 6B | CHF 55.21 | 3.41% down | 10% down | ||
| 47 | Belite BioBLTE · Health Care | CHF 658.2M | CHF 5.2B | CHF 128.78 | 2.25% down | 43% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | CHF 655.9M | CHF 7.9B | CHF 83.48 | 2.42% down | 332% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 644M | CHF 6.3B | CHF 79.71 | 0.56% down | 129% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | CHF 633.5M | CHF 7.1B | CHF 8.90 | 0.52% up | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | CHF 581.7M | CHF 6B | CHF 113.21 | 0.19% up | 6% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | CHF 563.5M | CHF 7B | CHF 107.35 | 0.11% up | 51% up | ||
| 53 | ABIVAXABVX · Health Care | CHF 546.7M | CHF 6.3B | CHF 71.59 | 1.26% up | 32% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | CHF 510.3M | CHF 4B | CHF 42.00 | 0.88% down | 45% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | CHF 466M | CHF 3.7B | CHF 34.11 | 2.22% down | 86% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | CHF 447.7M | CHF 4.1B | CHF 71.99 | 1.65% up | 108% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | CHF 412M | CHF 5.6B | CHF 82.73 | 2.47% up | 255% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 404.9M | CHF 6.8B | CHF 98.73 | 1.65% down | 18% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | CHF 371.1M | CHF 3.3B | CHF 24.07 | 1.97% down | 168% up | ||
| 60 | ErascaERAS · Health Care | CHF 334.1M | CHF 4.1B | CHF 11.79 | 1.60% up | 395% up | ||
| 61 | VeradermicsMANE · Health Care | CHF 128.7M | CHF 4.4B | CHF 104.10 | 1.13% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8433 CHF).
Questions and answers
Which health care pharmaceutical companies rank first by total assets?
Pfizer (CHF 175.5B), Johnson & Johnson (CHF 168B) and Sanofi (CHF 118.6B) are the top three of the 61 health care pharmaceutical companies ranked by total assets as of 19 Nov 2026, 15:40 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by total assets have a combined market value of CHF 4.19T as of 19 Nov 2026, 15:40 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.